Carson Wealth (CWM LLC)’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
FIA
ACA
MSCM
ACM
IWS
Carson Wealth (CWM LLC)'s IHE Position: Q1 2026 in Review
Carson Wealth (CWM LLC) reduced its iShares US Pharmaceuticals ETF (IHE) stake by 56% in Q1 2026, selling an estimated $38.2K and leaving 340 shares worth $29.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4177.
Carson Wealth (CWM LLC) first reported a position in IHE in Q4 2018 and has held it in 17 quarters since. The position peaked at $66K in Q4 2025. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.
- Carson Wealth (CWM LLC) held 340 shares of iShares US Pharmaceuticals ETF worth $29.4K as of Q1 2026.
- Carson Wealth (CWM LLC) sold 436 iShares US Pharmaceuticals ETF shares in Q1 2026, an estimated $38.2K.
- iShares US Pharmaceuticals ETF made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4177 holding.
- Carson Wealth (CWM LLC) first reported a position in iShares US Pharmaceuticals ETF in Q4 2018 and has held it in 17 quarters since.
- Carson Wealth (CWM LLC)'s iShares US Pharmaceuticals ETF position peaked at $66K in Q4 2025.
- 194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.